Anuh Pharma Reports Quarterly Results; Shareholders Withdraw Reclassification Requests

Anuh Pharma Reports Quarterly Results; Shareholders Withdraw Reclassification Requests

Anuh Pharma Reports Quarterly Results; Shareholders Withdraw Reclassification Requests​

Anuh Pharma Limited released its unaudited financial results for the quarter ending June 30, 2026. The company's board meeting, held on August 7, 2026, approved the quarterly performance figures and confirmed that several shareholders within the Promoter Group have withdrawn their requests for reclassification from the Promoter category to the public category.

The Board of Directors reviewed the un-audited financial results and also adopted a revised Policy on Related Party Transactions, which is available on the company’s website.

Financial Performance Highlights (Q Ended June 30, 2026)​

The quarterly unaudited results for Q ended June 30, 2026, show total revenue of Rs 19,688.71 Lakhs. The company recorded a Profit after Tax of Rs 1,142.49 Lakhs in the quarter.

Key financial metrics for the period ended June 30, 2026, stand as follows:

ParticularsQ Ended 30/06/2026 (Unaudited)Q Ended 31/03/2026 (Audited)Q Ended 30/06/2025 (Unaudited)12 Months Ended 31/03/2026 (Audited)
Revenue from operations19,381.04 Lakhs20,211.72 Lakhs18,647.94 Lakhs77,165.74 Lakhs
Total Revenue19,688.71 Lakhs20,086.26 Lakhs18,986.78 Lakhs77,601.30 Lakhs
Profit after Tax (IX)1,142.49 Lakhs1,168.14 Lakhs830.12 Lakhs4,104.61 Lakhs

The company’s EBITDA for the quarter ended June 30, 2026, was reported at Rs 1,936.44 Lakhs, corresponding to a EBITDA Margin of 9.99%. For the full 12 months ending March 31, 2026, the company reported an Adjusted EBITDA of Rs 6,784.24 Lakhs, or 8.79% of the margin.

Promoter Shareholders Withdraw Reclassification Requests​

The Board meeting confirmed that shareholders from the Promoter Group who had sought reclassification to the public category have withdrawn their respective requests. The shareholders and their shareholdings are detailed below:

NameNumber of Equity Shares Held% of Shareholding
Vikram Kirtilal Shah2000.00%
Kiran Piyush Shah15,3880.02%
Kinjal Siddharth Jhaveri8,16,1600.81%
TOTAL8,31,7480.83%

The withdrawal confirms that these shareholders will continue to be classified as members of the Promoter Group of Anuh Pharma Limited. The results include all share and per-share information reflecting previous bonus share issuances in the proportion of 1:1.

ANUHPHR Stock Price Movement​

Anuh Pharma Limited shares edged higher on Friday, closing at ₹79.32 after gaining 0.72% against the previous close. The stock traded within a daily range of ₹78.37 to ₹81.74, recording a volume of 103,463 shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top